
Homogeneous antibody-drug conjugates (ADCs) that use a highly reactive buried lysine (Lys) residue embedded in a dual variable domain (DVD)-IgG1 format can be assembled with high precision and efficiency under mild conditions. Here we show that replacing the Lys with an arginine (Arg) residue affords an orthogonal ADC assembly that is site-selective and stable. X-ray crystallography confirmed the location of the reactive Arg residue at the bottom of a deep pocket. As the Lys-to-Arg mutation is confined to a single residue in the heavy chain of the DVD-IgG1, heterodimeric assemblies that combine a buried Lys in one arm, a buried Arg in the other arm, and identical light chains, are readily assembled. Furthermore, the orthogonal conjugation chemistry enables the loading of heterodimeric DVD-IgG1s with two different cargos in a one-pot reaction and thus affords a convenient platform for dual-warhead ADCs and other multifaceted antibody conjugates.
Bioterrorism is an ongoing threat to global peace and health because weaponized agents are available to potential terrorist groups either directly or through scientists who may be willing to cooperate with terrorists. Biological weapons would have larger disastrous global health effects compared to chemical weapons. Therefore, there is a need for merging endeavors of the scientific community on the tasks of developing methodologies for prevention of biological attack/threat, for biological weapons control and for completing a biodefence system. This monograph is a result of such endeavors. 1.1 Control of Biological Weapons The scientific community should focus on two strategies: 1.1.1 Strategy of Intelligence There are no easily identifiable footprints marking bioweapons development as it is nearly indistinguishable from legitimate biological science and biotechnology, and such efforts are easily hidden in plain sight. Gathering intelligence on national level and limiting the illicit transfer of materials, technologies and knowledge, are not easy tasks. Furhter, the intelligence community should develop capability of tactical warning of a planned bioterrorist attack. In the aftermath of a bioattack the authorities want to know who the attacker was, how the attack was carried out and how the next attack could be stopped? Some of the multibillion dollar biodefence systems, such as Bio Watch in the U.S.A. that has been developed for years does not provide information on who and how attacked, V. Radosavljevic (*) Military Medical Headquarter, Ministry of Defence, Crnotravska 17, Belgrade, Serbia University of Defence, Belgrade, Serbia e-mail: vladanr4@gmail.com
The AMP-activated protein kinase (AMPK) alpha beta gamma het-erotrimer regulates cellular energy homeostasis with tissue-specific isoform distribution. Smallmolecule activation of skeletal muscle alpha 2 beta 2 AMPK complexes may prove a valuable treatment strategy for type 2 diabetes and insulin resistance. Herein, we report the small-molecule SC4 is a potent, direct AMPK activator that preferentially activates alpha 2 complexes and stimulates skeletal muscle glucose uptake. In parallel with the term secretagog, we propose "importagog" to define a substance that induces or augments cellular uptake of another substance. Three-dimensional structures of the glucose importagog SC4 bound to activated alpha 2 beta 2 gamma 1 and alpha 2 beta 1 gamma 1 complexes reveal binding determinants, in particular a key interaction between the SC4 imidazopyridine 4'-nitrogen and beta 2-Asp111, which provide a design paradigm for beta 2-AMPK therapeutics. The alpha 2 beta 2 gamma 1/SC4 structure reveals an interaction between a beta 2 N-terminal alpha helix and the alpha 2 autoinhibitory domain. Our results provide a structurefunction guide to accelerate development of potent, but importantly tissue-specific, beta 2-AMPK therapeutics.
This book describes the latest molecular insights needed to understand the chemical and biological (CB) agents and their associated biotechnologies. Its primary focus is to present and discuss molecul
This book highlights the current state-of-the-art regarding the application of applied crystallographic methodologies for understanding, predicting and controlling the transformation from the molecula